Sarepta Therapeutics
- Pharmaceutical Preparations
- Cambridge, Massachusetts
Compensation history
Top executives at Sarepta Therapeutics received an average of $3M per person in annual compensation from 2006 to 2021.
Average pay of disclosed executives at Sarepta Therapeutics
By year
- 2021
LR$9MLouise Rodino-KlapacExecutive Vice President, Head of R&D, Chief Scientific OfficerIE$5MIan M. EstepanExecutive Vice President, Chief Financial OfficerRB$5MRyan BrownSenior Vice President General CounselWC$5MWilliam CiambroneExecutive Vice President, Technical OperationsDI$2MDouglas IngramPresident and Chief Executive Officer- 2020
LR$7MLouise Rodino-KlapacExecutive Vice President, Chief Scientific OfficerDH$6MDavid Tyronne Howton, JrExecutive Vice President, General Counsel and Corporate SecretaryIE$5MIan M. EstepanExecutive Vice President, Chief Financial OfficerGM$4MGilmore O'Neill, M.B., M.M.ScExecutive Vice President, Chief Scientific OfficerSM$3MSandesh MahatmeExecutive Vice President, Chief Financial Officer and Chief Business OfficerDI$1MDouglas IngramPresident and Chief Executive OfficerJB$912KJoseph BraticaVice President, Corporate ControllerWC$680KWilliam CiambroneExecutive Vice President, Technical Operations- 2019
GM$5MGilmore O'Neill, M.B., M.M.ScExecutive Vice President, Chief Scientific OfficerSM$5MSandesh MahatmeExecutive Vice President, Chief Financial Officer and Chief Business OfficerWC$4MWilliam CiambroneExecutive Vice President, Technical OperationsDH$4MDavid Tyronne Howton, JrExecutive Vice President, General Counsel and Corporate SecretaryDI$1MDouglas IngramPresident and Chief Executive Officer
Executives
We found 31 executives who work or worked at Sarepta Therapeutics.
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
Ryan Brown
Sarepta Therapeutics
General Counsel
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
Joseph Bratica
Sarepta Therapeutics
Vice President, Corporate Controller
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
News
Sarepta Therapeutics CSO Louise Rodino-Klapac's 2021 pay rises 17% to $8.5M
April 25, 2022
Sarepta Therapeutics CSO Louise Rodino-Klapac receives $7.3M in 2020
April 20, 2021
Sarepta Therapeutics CSO Gilmore MMSc's 2019 pay slips 20% to $5.2M
April 21, 2020
Sarepta Therapeutics CSO Gilmore MMSc receives $6.4M in 2018
April 26, 2019
About Sarepta Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address215 First Street, Suite 415, Cambridge, Massachusetts 02142
- Phone617-274-4000
- Fiscal year endDecember 31
- Former names
- AVI BIOPHARMA INCUntil July 11, 2012
- ANTIVIRALS INCUntil May 11, 1998
Source: SEC filings on April 25, 2022, April 20, 2021, April 21, 2020, April 26, 2019, April 26, 2018, April 27, 2017, April 30, 2015, May 31, 2016, April 30, 2013, May 4, 2010, April 14, 2009, and April 17, 2007.